Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Nootropics Market by Type (Attention and Focus, Memory Enhancement, Mood and Depression, Sleep and Anxiety, Others), By Application (Adult, Kid) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Nootropics Market by Type (Attention and Focus, Memory Enhancement, Mood and Depression, Sleep and Anxiety, Others), By Application (Adult, Kid) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 130286 3300 Pharma & Healthcare 377 243 Pages 4.6 (37)
                                          

Market Overview:


The global nootropics market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising awareness about the benefits of nootropics, increasing demand for cognitive enhancers, and growing popularity of brain-training games. However, stringent regulatory norms and lack of standardization are some factors that could hamper the growth of this market. The global nootropics market is segmented on the basis of type, application, and region. On the basis of type, it is divided into attention and focus supplements, memory enhancement supplements, mood and depression supplements, sleep and anxiety supplements, and others (including energy boosters and weight loss supplements). On the basis of application it is classified into adult applications (such as students) and kid applications (such as toddlers). Region wise it covers North America (the U.S., Canada), Latin America (Brazil), Europe (Germany), Asia Pacific excluding Japan) Japan), Middle East & Africa(South Africa).


Global Nootropics Industry Outlook


Product Definition:


Nootropics are drugs, supplements, or other substances that improve cognitive function. The use of nootropics is growing in popularity as people seek to improve their focus, memory, and mental clarity. Nootropics are important for students who want to achieve peak performance in school and professionals who want to stay sharp during intense work periods.


Attention and Focus:


Attention and focus are two separate yet interrelated aspects of human consciousness. While attention is the cognitive process of focusing on a particular object or region in our surroundings, focus is the mental state when we are able to maintain awareness for a particular task.


The ability to control one’s attention is considered as an important skill for success in any field such as education, sports, and business.


Memory Enhancement:


Memory enhancement is the process through which the body’s cells, tissues and organs are stimulated to grow and develop more quickly. It helps in improving memory, attention span & concentration as well as it enhances learning ability. The nootropic drugs help in enhancing memory by improving blood flow to the brain, increasing acetylcholine (ACh) levels in the brain or by blocking enzymes that break down ACh.


Application Insights:


The adult application segment dominated the global nootropics market in 2017. This can be attributed to the growing preference for smart drugs by working professionals to help them perform at their best. The memory enhancement type of nootropics is most commonly used by adults as it helps in improving short-term and long-term memory, concentration and learning abilities.


The kid application segment is expected to witness significant growth over the forecast period owing to rising usage of smart drugs for academic performance among school children and students from elementary level till graduation. The increasing use of these supplements among schoolchildren and students from elementary level till graduation can be attributed to improved academic performance along with enhanced concentration and mental alertness in a span of 2-3 hours after taking a dose. These are available without prescription, which makes them easily accessible even though health experts recommend against its consumption until age 18 years or above due largely due to lack of clinical evidence regarding its safety for human consumption beyond that age group.


Regional Analysis:


North America dominated the global nootropics market in 2016. The region is expected to maintain its position during the forecast period. This can be attributed to increasing R&D investments, rising adoption of smart drugs, and growing focus on mental wellbeing among individuals belonging to various socio-economic groups and age groups in the region.


Asia Pacific is anticipated to witness significant growth over the next eight years owing to increasing awareness about brain health and functioning among consumers from China, Japan, Singapore, South Korea & India who form a large part of this regional market due to their high purchasing power.


The European market also contributed significantly towards revenue generation in 2016 as it was one of the first regions where products were launched after North America & Asia Pacific markets had been well defined by manufacturers & end users respectively.


Growth Factors:


  • Increasing awareness about the benefits of nootropics and their potential to improve cognitive function.
  • Growing demand from students and professionals for products that can help them boost productivity and focus.
  • Rising popularity of nootropic stacks, which allow users to customize their own cognitive enhancement regimens.
  • Proliferation of online retailers selling nootropic supplements at competitive prices.

Scope Of The Report

Report Attributes

Report Details

Report Title

Nootropics Market Research Report

By Type

Attention and Focus, Memory Enhancement, Mood and Depression, Sleep and Anxiety, Others

By Application

Adult, Kid

By Companies

Nootrobox, Cephalon, Purelife Bioscience, Peak Nootropics, Nootrico, SupNootropic Biological Technology, AlternaScript, Accelerated Intelligence, Onnit Labs, Powder City, Ceretropic, Nootropic Source, Clarity Nootropics

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

243

Number of Tables & Figures

171

Customization Available

Yes, the report can be customized as per your need.


Global Nootropics Market Report Segments:

The global Nootropics market is segmented on the basis of:

Types

Attention and Focus, Memory Enhancement, Mood and Depression, Sleep and Anxiety, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Adult, Kid

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Nootrobox
  2. Cephalon
  3. Purelife Bioscience
  4. Peak Nootropics
  5. Nootrico
  6. SupNootropic Biological Technology
  7. AlternaScript
  8. Accelerated Intelligence
  9. Onnit Labs
  10. Powder City
  11. Ceretropic
  12. Nootropic Source
  13. Clarity Nootropics

Global Nootropics Market Overview


Highlights of The Nootropics Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of Alpha Hydroxy Acid for Cosmetic Market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Attention and Focus
    2. Memory Enhancement
    3. Mood and Depression
    4. Sleep and Anxiety
    5. Others
  1. By Application:

    1. Adult
    2. Kid
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Nootropics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Nootropics Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available
                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Nootropics Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Nootropics Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Nootropics Market - Supply Chain
   4.5. Global Nootropics Market Forecast
      4.5.1. Nootropics Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Nootropics Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Nootropics Market Absolute $ Opportunity

5. Global Nootropics Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Nootropics Market Size and Volume Forecast by Type
      5.3.1. Attention and Focus
      5.3.2. Memory Enhancement
      5.3.3. Mood and Depression
      5.3.4. Sleep and Anxiety
      5.3.5. Others
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Nootropics Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Nootropics Market Size and Volume Forecast by Application
      6.3.1. Adult
      6.3.2. Kid
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Nootropics Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Nootropics Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Nootropics Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Nootropics Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Nootropics Demand Share Forecast, 2019-2029

9. North America Nootropics Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Nootropics Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Nootropics Market Size and Volume Forecast by Application
      9.4.1. Adult
      9.4.2. Kid
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Nootropics Market Size and Volume Forecast by Type
      9.7.1. Attention and Focus
      9.7.2. Memory Enhancement
      9.7.3. Mood and Depression
      9.7.4. Sleep and Anxiety
      9.7.5. Others
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Nootropics Demand Share Forecast, 2019-2029

10. Latin America Nootropics Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Nootropics Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Nootropics Market Size and Volume Forecast by Application
      10.4.1. Adult
      10.4.2. Kid
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Nootropics Market Size and Volume Forecast by Type
      10.7.1. Attention and Focus
      10.7.2. Memory Enhancement
      10.7.3. Mood and Depression
      10.7.4. Sleep and Anxiety
      10.7.5. Others
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Nootropics Demand Share Forecast, 2019-2029

11. Europe Nootropics Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Nootropics Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Nootropics Market Size and Volume Forecast by Application
      11.4.1. Adult
      11.4.2. Kid
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Nootropics Market Size and Volume Forecast by Type
      11.7.1. Attention and Focus
      11.7.2. Memory Enhancement
      11.7.3. Mood and Depression
      11.7.4. Sleep and Anxiety
      11.7.5. Others
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Nootropics Demand Share, 2019-2029

12. Asia Pacific Nootropics Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Nootropics Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Nootropics Market Size and Volume Forecast by Application
      12.4.1. Adult
      12.4.2. Kid
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Nootropics Market Size and Volume Forecast by Type
      12.7.1. Attention and Focus
      12.7.2. Memory Enhancement
      12.7.3. Mood and Depression
      12.7.4. Sleep and Anxiety
      12.7.5. Others
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Nootropics Demand Share, 2019-2029

13. Middle East & Africa Nootropics Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Nootropics Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Nootropics Market Size and Volume Forecast by Application
      13.4.1. Adult
      13.4.2. Kid
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Nootropics Market Size and Volume Forecast by Type
      13.7.1. Attention and Focus
      13.7.2. Memory Enhancement
      13.7.3. Mood and Depression
      13.7.4. Sleep and Anxiety
      13.7.5. Others
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Nootropics Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Nootropics Market: Market Share Analysis
   14.2. Nootropics Distributors and Customers
   14.3. Nootropics Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Nootrobox
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Cephalon
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Purelife Bioscience
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Peak Nootropics
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Nootrico
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. SupNootropic Biological Technology
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. AlternaScript
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Accelerated Intelligence
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Onnit Labs
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Powder City
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Ceretropic
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. Nootropic Source
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. Clarity Nootropics
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us